The molecular basis of type 1 glycogen storage diseases

Current Molecular Medicine
J Y Chou

Abstract

Glycogen storage disease type 1 (GSD-1), also known as von Gierke disease, is a group of autosomal recessive metabolic disorders caused by deficiencies in the activity of the glucose-6-phosphatase (G6Pase) system that consists of at least two membrane proteins, glucose-6-phosphate transporter (G6PT) and G6Pase. G6PT translocates glucose-6-phosphate (G6P) from cytoplasm to the lumen of the endoplasmic reticulum (ER) and G6Pase catalyzes the hydrolysis of G6P to produce glucose and phosphate. Therefore, G6PT and G6Pase work in concert to maintain glucose homeostasis. Deficiencies in G6Pase and G6PT cause GSD-1a and GSD-1b, respectively. Both manifest functional G6Pase deficiency characterized by growth retardation, hypoglycemia, hepatomegaly, kidney enlargement, hyperlipidemia, hyperuricemia, and lactic acidemia. GSD-1b patients also suffer from chronic neutropenia and functional deficiencies of neutrophils and monocytes, resulting in recurrent bacterial infections as well as ulceration of the oral and intestinal mucosa. The G6Pase gene maps to chromosome 17q21 and encodes a 36-kDa glycoprotein that is anchored to the ER by 9 transmembrane helices with its active site facing the lumen. Animal models of GSD-1a have been developed ...Continue Reading

Citations

Nov 27, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yoshinao Wada
Oct 5, 2010·Expert Reviews in Molecular Medicine·Evangelia YannakiGeorge Stamatoyannopoulos
Jun 24, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Albert GrinshpunEithan Galun
May 5, 2007·Journal of Toxicology and Environmental Health. Part a·Yu-Jie ZhuJian-Wei Zhou
Jul 6, 2011·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Juli J Unternaehrer, George Q Daley
Oct 15, 2003·Clinical Microbiology Reviews·Timothy Andrews, Kathleen E Sullivan
Sep 14, 2011·Annual Review of Pathology·Ronald S FlannaganSergio Grinstein
Oct 22, 2015·Proceedings of the National Academy of Sciences of the United States of America·Tiffany FleetBrian York
Apr 5, 2016·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Balázs SziliIstván Takács
Apr 5, 2014·The Journal of Allergy and Clinical Immunology·Atfa SassiBodo Grimbacher
Sep 16, 2016·Oral Diseases·M E PeacockC W Cutler
Apr 9, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Daniela MelisGiuseppe Matarese
Jun 8, 2018·The Journal of Endocrinology·Sara S Ellingwood, Alan Cheng
Oct 26, 2018·Annual Review of Pathology·Rodrigo GrandyLudovic Vallier
Apr 15, 2016·Molecular Endocrinology·Haojie Yu, Chad A Cowan
Mar 16, 2007·American Journal of Physiology. Endocrinology and Metabolism·Ji Young KimCynthia M Smas
Oct 7, 2004·Endocrine Reviews·Clara BouchéAllison B Goldfine
Oct 31, 2006·World Journal of Gastroenterology : WJG·Yoshiyuki TakaharaNorifumi Kawada
Oct 13, 2020·Frontiers in Pediatrics·Bilal AounPascale E Karam
Nov 20, 2004·Diabetes/metabolism Research and Reviews·Alberto MaranAntonio Tiengo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.